Neovasc Inc. (Neovasc) is a specialty medical device company that develops, manufactures and markets products for the cardiovascular marketplace. Its products include the Neovasc Reducer for the treatment of refractory angina, the Tiara technology in development for the transcatheter treatment of mitral valve disease and a line of advanced biological tissue products that are used as key components in a variety of third-party medical products, such as vascular surgical patches and transcatheter heart valves. Neovasc manufactures the PeriPatch line of advanced biological tissue products that are manufactured from pericardium, which is the protective sac that surrounds the heart of an animal. The product line includes the PeriPatch Sheet, and PeriPatch EQ Sheet, which are rectangular patches made from bovine (cow) or equine (horse) tissue, applied as internal bandages to repair weak or damaged organs or vessels.